You are here:

tadalafil (Cialis)

Advice

In the absence of a submission from the holder of the marketing authorisation: tadalafil (Cialis) is not recommended for use within NHS Scotland.

Indication under review: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: tadalafil (Cialis)
SMC Drug ID: 849/12
Manufacturer: Eli Lilly and Company Ltd
Indication: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
BNF Category:
Sub Category: 7.4 Drugs for genito-urinary disorders
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 14 January 2013

Back